BioHealth News Archive
Regional startups find support at annual GMU Accelerate Investor Conference
The Accelerate Investor Conference spurs the region’s innovation and startup ecosystem engagement to a new level and showcases the Virginia, Maryland, and metropolitan Washington,…
Read More
Updated Save the Date, Mark your calendars now. 11th Annual BioHealth Capital Region Week Rescheduled for September 23-25, 2025!
The 11th Annual BioHealth Capital Region Week has been rescheduled to take place from September 23rd through 25th, 2025, at USP in Rockville, Maryland.…
Read More
U.S. FDA Removes Clinical Hold on Novavax’s COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial
GAITHERSBURG, Md., Nov. 11, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that the U.S.…
Read More
Altimmune Announces Successful Completion of End-of-Phase 2 Meeting with FDA for Pemvidutide in the Treatment of Obesity
GAITHERSBURG, Md., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced the successful completion of its End-of-Phase 2 Meeting…
Read More
WBJ: Novavax taps AstraZeneca, Pfizer alum to lead key manufacturing site
Novavax Inc. (NASDAQ: NVAX) has tapped AstraZeneca and Pfizer alum Åsa Manelius to oversee operations at the Swedish lab where it manufactures a key vaccine ingredient that's expected to help drive…
Read More
Bethesda’s Vitrian Closes on $50M Initial Investment into Biomanufacturing Capacity & Launches Partnership with AmplifyBio
BETHESDA, Md. & WEST JEFFERSON, Ohio--(BUSINESS WIRE)--Vitrian, the leading end-to-end provider of investment capital and capacity building services for biomanufacturing, announced today that it…
Read More
Catalyzing Crucial Cross-Border Collaborations and Innovation to Address Unmet Needs in Rare Diseases
The Indo US Bridging RARE Summit 2024 will spotlight the urgent need for cross-border collaborations to address disparities in rare disease treatment by bringing…
Read More
Activation Capital Announces Frontier BioHealth Showcase Event
10 groundbreaking startups to pitch at Richmond's Main Street Station on November 20, 2024 RICHMOND, Va., Nov. 4, 2024 /PRNewswire/ -- Activation Capital, an innovation ecosystem development organization, is thrilled…
Read More
QIAGEN receives FDA clearance of QIAstat-Dx meningitis/encephalitis panel to support emergency diagnostics
Germantown, Maryland, and Venlo, the Netherlands, Nov. 04, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the U.S.…
Read More
Baltimore’s LaunchPort Welcomes Previous Crab Trap Winner, Nanochon, from JLABS as New Resident
Nov 3, 2024 LaunchPort is pleased to announce that Nanochon (https://www.nanochon.com/) has joined their City Garage/Baltimore Peninsula location as a LaunchPort Resident. Nanochon’s mission…
Read More
BioTalk Podcast – Connecting Innovation to Opportunity: A Conversation with Rachel Rath, Head of JLABS @ Washington, DC
In this episode of BioTalk, Rich Bendis sits down with Rachel Rath, the Head of JLABS @ Washington, DC, to discuss her journey and…
Read More
Join the Indo US Bridging RARE Summit 2024: Advancing Global Collaborations in Rare Disease Research
The Indo US Bridging RARE Summit 2024 is set to be an unmissable event for those dedicated to advancing rare disease research and fostering…
Read More
BioFactura Receives $7.8 Million in Funding for Contract Options for its Smallpox Biodefense Therapeutic
FREDERICK, MARYLAND, November 4, 2024: BioFactura, Inc. recently announced contract option activations totaling $7.8 million by the Biomedical Advanced Research and Development Authority (BARDA),…
Read More
TEDCO Invests in NeuroIntact
COLUMBIA, Md., (October 31, 2024) — TEDCO, Maryland’s economic engine for technology companies, announced a recent $250,000 Seed Funds investment in NeuroIntact. TEDCO’s Seed Funds aim to…
Read More
QIAGEN receives FDA clearance for QIAstat-Dx mini panel to improve precision in outpatient respiratory treatment
Germantown, Maryland, and Venlo, the Netherlands, Oct. 29, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the U.S.…
Read More